Anavex: Looking At Different Statistical Approaches Before EMA Opinion
Anavex Life Sciences Corp.'s stock rises 50% as EMA reviews Alzheimer's drug blarcamesine. Click for my updated look at AVXL stock and why I have upgraded it.
Stock Market Highlights: Nifty faces bearish reversal after 8th straight loss
A long bear candle was formed on the weekly chart, which indicates a reversal on the downside after the two weeks of upside ...
GBP/USD gains ground as risk appetite takes a step up
After weeks of bullish effort, GBP/USD is finally back above the 50-day Exponential Moving Average (EMA) near the 1.2500 ...
Dow Jones Industrial Average gains ground as investors shrug off new tariff threats
The Dow Jones rose on Thursday, testing near 44,750. Equities are cautiously optimistic after PPI numbers softened inflation ...
The TRADE2d
ESMA thwarts European trajectory crossing plans with last minute rule change
Changes will halt European plans by Cboe, Aquis and PureStream – powered by Nasdaq – to launch trajectory offerings on the ...
Trade Spotlight: How should you trade Tata Steel, Kotak Mahindra Bank, Hero MotoCorp, UPL, Chambal Fertilisers, and other on February 11?
The market may attempt a rebound after the four-day loss, but sustainability will be key. Below are some trading ideas for ...
The National Law Review4d
SEC Extends Compliance Date for Short Sale Reporting Rule to 2026
On February 6, 2025, the SEC announced that it was providing a temporary exemption from compliance with Rule 13f-2 under the ...